Ankyra
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments. Systemic dosing of these potent immune stimulants is restricted due to widespread immune activation and toxicity. When cytokines are injected into tumor tissue, they localize specifically and persistently, causing intense hot spots of inflammation that activate an anti-tumor immune response. Ankyra used its Anchored Immunotherapy Platform to develop ANK-101, a stable complex of a modified IL-12 cytokine with aluminum hydroxide (Alhydrogel) to overcome the limitations of traditional cytokine therapeutics. Alhydrogel, an FDA-approved adjuvant for use in human and veterinary vaccines, acts as a scaffold to locally retain the potent activity of IL-12 after intratumoral administration, improving its therapeutic window. Ankyra's mission is to optimize the impact of anchored immunotherapy to improve the lives of patients with cancer.
Company details
- Website
- ankyratx.com
- Location
- Boston, United States
- Industry
- Biotechnology, Oncology
- Employees
- 1-10
- Verified emails available
- 0
Key people at Ankyra
- Darrell Irvine
- K. Dane Wittrup
Reveal Ankyra's verified founder emails on FindMeMail (free account, 50 free reveals).
Frequently asked questions
What is Ankyra?
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments. Systemic dosing of these potent immune stimulants is restricted due to widespread immune activation and toxicity. When cytokines are injected into tumor tissue, they localize specifically and persistently, causing intense hot spots of inflammation that activate an anti-tumor immune response. Ankyra used its Anchored Immunotherapy Platform to develop ANK-101, a stable complex of a modified IL-12 cytokine with aluminum hydroxide (Alhydrogel) to overcome the limitations of traditional cytokine therapeutics. Alhydrogel, an FDA-approved adjuvant for use in human and veterinary vaccines, acts as a scaffold to locally retain the potent activity of IL-12 after intratumoral administration, improving its therapeutic window. Ankyra's mission is to optimize the impact of anchored immunotherapy to improve the lives of patients with cancer.
Who are the key people at Ankyra?
Darrell Irvine, K. Dane Wittrup.
How do I find the email address of Ankyra's founder?
FindMeMail does not have a verified email for Ankyra yet. You can try the Email Finder at findmemail.io/email-finder.
Similar Biotechnology companies
- NEXTGENLABSUK LTD — Tiverton, United Kingdom: NEXTGENLABSUK supplies research peptides, compound bundles, and laboratory solutions for in‑vitro scientific research use only.
- NAION LTD: Naion Consultancy provides circular economy, sustainability, and renewable materials consulting services to industrial clients.
- Insevo: Insevo develops automated insect farming technology and produces insect-based protein solutions for sustainable feed and food applications.
- NAVIGATE PRECISION BIOLOGY LIMITED: Navigate Precision Biology develops 3D spheroid and organoid models and tools for translational drug discovery and disease modelling.
- HUMICINE LIFESCIENCE LLP — Rajkot, India: Humicine Lifescience develops pharmaceutical formulations with a focus on pediatric therapies and essential mineral products.
- BIONEXIS RESEARCH LTD — London, United Kingdom: Bionexis Peptides supplies high-purity synthetic peptides and biochemical reagents for scientific and analytical research use.
- ROSCODE TECH: ROSCODE TECH builds AI-driven, human-focused tools for health, productivity, and science, making advanced innovation accessible.
- INTELLIGENE DIAGNOSTICS LTD — Oxford, United Kingdom: IntelliGene Diagnostics provides molecular diagnostics and genomics consulting for life sciences, biopharma, and healthcare projects.
- Aqva.ai OÜ — Tallinn, Estonia: AQVA AI provides AI-enabled metagenomic diagnostics and predictive health intelligence for disease detection in aquaculture.
- Nando — Tallinn, Estonia: Nando Estonia distributes biological fertilizers, biostimulants, surfactants, and microbial technologies for agricultural applications.
- EVISYNA PRIVATE LIMITED — Hyderabad, India: Evisyna develops AI-driven software that supports evidence-based medicine through automated clinical literature review and research analysis
- Myorenova: Myorenova is a biomedical startup developing InjectaGel.